44.96 USD
+0.33 (+0.74%)
44.97 USD
+0.01 (+0.02%)
ChartMill assigns a Buy % Consensus number of 53% to CERE. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 44.27. This target is -1.54% below the current price.
CERE was analyzed by 14 analysts. The buy percentage consensus is at 53. So analysts seem to be rather neutral about CERE.
In the previous month the buy percentage consensus was at a similar level.
CERE was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-02-16 | Mizuho | Maintains | Neutral -> Neutral |
| 2023-12-28 | JP Morgan | Maintains | Neutral -> Neutral |
| 2023-12-22 | Jefferies | Downgrade | Buy -> Hold |
| 2023-12-08 | TD Cowen | Downgrade | Outperform -> Market Perform |
| 2023-12-07 | Cantor Fitzgerald | Downgrade | Overweight -> Neutral |
| 2023-12-07 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2023-12-07 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2023-11-20 | JP Morgan | Reiterate | Neutral |
| 2023-11-02 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-09-28 | Piper Sandler | Initiate | Overweight |
| 2023-08-07 | Mizuho | Maintains | Neutral -> Neutral |
| 2023-08-03 | B of A Securities | Downgrade | Buy -> Neutral |
| 2023-08-03 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-08-03 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-05-23 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2023-05-08 | Mizuho | Maintains | Neutral |
| 2023-05-04 | Wells Fargo | Upgrade | Equal-Weight -> Overweight |
| 2023-04-10 | TD Cowen | Initiate | Outperform |
| 2023-04-03 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-17 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2023-03-16 | Berenberg | Reiterate | Hold |
| 2023-03-09 | Mizuho | Maintains | Neutral |
| 2023-02-23 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2023-02-23 | Morgan Stanley | Maintains | Overweight |
| 2023-02-23 | HC Wainwright & Co. | Maintains | Buy |
| 2022-12-06 | JP Morgan | Maintains | Overweight |
| 2022-11-10 | Mizuho | Maintains | Neutral |
| 2022-11-09 | HC Wainwright & Co. | Maintains | Buy |
| 2022-11-01 | Loop Capital | Initiate | Buy |
| 2022-10-20 | B of A Securities | Initiate | Buy |
CEREVEL THERAPEUTICS HOLDING / CERE FAQ
What do analysts expect the price target to be for CEREVEL THERAPEUTICS HOLDING (CERE)?
14 analysts have analysed CERE and the average price target is 44.27 USD. This implies a price decrease of -1.54% is expected in the next year compared to the current price of 44.96.
What is the consensus rating for CERE stock?
The consensus rating for CEREVEL THERAPEUTICS HOLDING (CERE) is 52.8571 / 100 . This indicates that analysts generally have a neutral outlook on the stock.